Amarin Corp Plcuk (AMRN) Operating Leases (2019 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Operating Leases of $7.2 million for Q2 2026, down 25.0% year-over-year from $9.6 million in Q2 2025, and down 6.49% quarter-over-quarter from $7.7 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Operating Leases (2019 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Operating Leases for 8 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Leases fell 25.0% year-over-year to $7.2 million; the TTM figure through Jun 2026 stood at $7.2 million (down 25.0% YoY), while the FY2025 annual figure was $8.2 million, down 15.46% from the prior year.
- Operating Leases slipped to $7.2 million in Q2 2026 per AMRN's latest filing, from $7.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $11.7 million in Q1 2023 and bottomed at $7.2 million in Q2 2026.
- Historically, Operating Leases has averaged $10.1 million across 5 years, with a median of $10.2 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases jumped 35.26% — and 2026, when it declined 25.24%.
- Amarin Corp Plc\Uk's Operating Leases stood at $11.6 million in 2022, then declined by 8.62% to $10.6 million in 2023, then dropped by 8.49% to $9.7 million in 2024, then dropped by 15.46% to $8.2 million in 2025, then dropped by 12.2% to $7.2 million in 2026.
- Business Quant data shows AMRN's Operating Leases at $7.2 million in Q2 2026, $7.7 million in Q1 2026, and $8.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.75 Bn | 633.00 Bn | 17.26 Bn |
| 2 | AbbVie | 470.62 Bn | 464.05 Bn | 12.70 Bn |
| 3 | Merck | 376.18 Bn | 369.04 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.75 Bn | 296.06 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.67 Bn | 252.77 Bn | 12.86 Bn |
| 6 | Amgen | 236.39 Bn | 222.40 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.04 Bn | 178.86 Bn | 6.22 Bn |
| 8 | Pfizer | 159.49 Bn | 147.79 Bn | 10.94 Bn |
| 9 | Gsk | 106.27 Bn | 102.10 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.87 Bn | 5.56 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.20 Mn |
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 8.20 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 10.30 Mn |
| Dec 31, 2024 | 9.70 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | 9.70 Mn |
| Mar 31, 2024 | 10.10 Mn |
| Dec 31, 2023 | 10.60 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Jun 30, 2023 | 11.40 Mn |
| Mar 31, 2023 | 11.70 Mn |
| Dec 31, 2022 | 11.60 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 11.20 Mn |
| Mar 31, 2022 | 11.30 Mn |
| Dec 31, 2021 | 8.58 Mn |
| Sep 30, 2021 | 10.50 Mn |